HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Pseudohypoparathyroidism: complex disease variants with unfortunate names.

Abstract
Several human disorders are caused by genetic or epigenetic changes involving the GNAS locus on chromosome 20q13.3 that encodes the alpha-subunit of the stimulatory G protein (Gsα) and several splice variants thereof. Thus, pseudohypoparathyroidism type Ia (PHP1A) is caused by heterozygous inactivating mutations involving the maternal GNAS exons 1-13 resulting in characteristic abnormalities referred to as Albright's Hereditary Osteodystrophy (AHO) that are associated with resistance to several agonist ligands, particularly to parathyroid hormone (PTH), thereby leading to hypocalcemia and hyperphosphatemia. GNAS mutations involving the paternal Gsα exons also cause most of these AHO features, but without evidence for hormonal resistance, hence the term pseudopseudohypoparathyroidism (PPHP). Autosomal dominant (AD) pseudohypoparathyroidism type Ib (AD-PHP1B) due to maternal GNAS or STX16 mutations (deletions, duplications, insertions, and inversions) is associated with epigenetic changes at one or several Differentially Methylated Regions (DMR) within GNAS. Unlike the inactivating Gsα mutations that cause PHP1A and PPHP, hormonal resistance is caused in all PHP1B variants by impaired Gsα expression due to loss-of-methylation at GNAS exon A/B, which can be associated in some familial cases with epigenetic changes at the other maternal GNAS DMRs. The genetic defect(s) responsible for sporadic PHP1B (sporPHP1B), the most frequent variant of this disorder, remains unknown for the majority of patients. However, characteristic epigenetic GNAS changes can be readily detected that include a gain-of-methylation at the NESP DMR. Multiple genetic or epigenetic GNAS abnormalities thus impair Gsα function or expression, consequently leading to inadequate cAMP-dependent signaling events down-stream of various Gsα-coupled receptors.
AuthorsHarald Jüppner
JournalJournal of molecular endocrinology (J Mol Endocrinol) (Nov 01 2023) ISSN: 1479-6813 [Electronic] England
PMID37965945 (Publication Type: Journal Article, Review)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: